These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 1322674)
1. Effect of pamidronate in a rat hypercalcemia model induced by cholecalciferol. Okada M; Noguchi S; Hasegawa Y; Inukai T Arzneimittelforschung; 1992 Apr; 42(4):543-6. PubMed ID: 1322674 [TBL] [Abstract][Full Text] [Related]
2. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia. Sekine M; Takami H Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321 [TBL] [Abstract][Full Text] [Related]
3. Calcitonin therapy in prolonged immobilization hypercalcemia. Carey DE; Raisz LG Arch Phys Med Rehabil; 1985 Sep; 66(9):640-4. PubMed ID: 4038033 [TBL] [Abstract][Full Text] [Related]
4. Use of pamidronate to reverse vitamin D3-induced toxicosis in dogs. Rumbeiha WK; Kruger JM; Fitzgerald SF; Nachreiner RF; Kaneene JB; Braselton WE; Chiapuzio CL Am J Vet Res; 1999 Sep; 60(9):1092-7. PubMed ID: 10490077 [TBL] [Abstract][Full Text] [Related]
5. Vitamin D3 and calcitonin-induced regulation of calcium and phosphate in rat lens--its significance in cataract formation. Srivastava VK; Srivastava SK Ann Ophthalmol; 1989 Apr; 21(4):149-52. PubMed ID: 2543257 [TBL] [Abstract][Full Text] [Related]
6. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism. Jansson S; Tisell LE; Lindstedt G; Lundberg PA Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370 [TBL] [Abstract][Full Text] [Related]
7. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin. Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663 [TBL] [Abstract][Full Text] [Related]
8. Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children. Schmid I; Stachel D; Schön C; Bauer M; Haas RJ Klin Padiatr; 2001; 213(1):30-4. PubMed ID: 11225473 [TBL] [Abstract][Full Text] [Related]
9. Effect of combination treatment with a vitamin D analog (OCT) and a bisphosphonate (AHPrBP) in a nude mouse model of cancer-associated hypercalcemia. Endo K; Katsumata K; Iguchi H; Kubodera N; Teramoto T; Ikeda K; Fujita T; Ogata E J Bone Miner Res; 1998 Sep; 13(9):1378-83. PubMed ID: 9738509 [TBL] [Abstract][Full Text] [Related]
10. Reproduction toxicity studies with pamidronate. Graepel P; Bentley P; Fritz H; Miyamoto M; Slater SR Arzneimittelforschung; 1992 May; 42(5):654-67. PubMed ID: 1530681 [TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of safety and efficacy of pamidronate and zoledronic acid in multiple myeloma patients (single center experience). Kraj M; Pogłód R; Maj S; Pawlikowski J; Sokołowska U; Szczepanik J Acta Pol Pharm; 2002; 59(6):478-82. PubMed ID: 12669777 [TBL] [Abstract][Full Text] [Related]
12. [Medical treatment of malignant hypercalcemia]. Eto S; Nakano Y; Okada Y Gan To Kagaku Ryoho; 1993 Dec; 20(15):2311-8. PubMed ID: 8259844 [TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
14. Changes in calcium homoeostasis in patients undergoing liver transplantation: effects of a single infusion of pamidronate administered pre-operatively. Bishop NJ; Ninkovic M; Alexander GJ; Holmes SD; Milligan T; Price C; Compston JE Clin Sci (Lond); 1999 Aug; 97(2):157-63. PubMed ID: 10409470 [TBL] [Abstract][Full Text] [Related]
15. The effects of the antiresorptive agents calcitonin and pamidronate on spine fusion in a rabbit model. Babat LB; McLain R; Milks R; Ferrara L; Sohn MJ Spine J; 2005; 5(5):542-7. PubMed ID: 16153583 [TBL] [Abstract][Full Text] [Related]
16. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors. Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357 [TBL] [Abstract][Full Text] [Related]
17. [Disodium pamidronate (APD) in therapy of hypercalcemia in primary hyperparathyroidism]. Kotzmann H; Svoboda T; Bernecker P; Clodi M; Woloszczuk W; Niederle B; Waldhäusl W; Luger A Wien Klin Wochenschr; 1994; 106(13):422-5. PubMed ID: 8091766 [TBL] [Abstract][Full Text] [Related]
18. Effect of pamidronate on the stimulation of macrophage TNF-alpha release by ultra-high-molecular-weight polyethylene particles: a role for apoptosis. Huk OL; Zukor DJ; Antoniou J; Petit A J Orthop Res; 2003 Jan; 21(1):81-7. PubMed ID: 12507583 [TBL] [Abstract][Full Text] [Related]
19. Current management strategies for hypercalcemia. Pecherstorfer M; Brenner K; Zojer N Treat Endocrinol; 2003; 2(4):273-92. PubMed ID: 15966562 [TBL] [Abstract][Full Text] [Related]
20. Use of pamidronate disodium to reduce cholecalciferol-induced toxicosis in dogs. Rumbeiha WK; Fitzgerald SD; Kruger JM; Braselton WE; Nachreiner R; Kaneene JB; Frese KK Am J Vet Res; 2000 Jan; 61(1):9-13. PubMed ID: 10630770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]